Hedge Fund - Aquilo Capital Management
Blueprint Medicines Corp (BPMC)
Holding History Records
No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
---|---|---|---|---|---|
1 | 2024 - Q4 (2024-12-31) | $11,303,712 | 17.04% | 129,600 | $91.60 |
2 | 2024 - Q3 (2024-09-30) | $11,525,500 | 8.73% | 124,600 | $99.33 |
3 | 2024 - Q2 (2024-06-30) | $12,351,588 | 11.9% | 114,600 | $100.09 |
4 | 2024 - Q1 (2024-03-31) | $17,278,844 | 12.95% | 182,151 | $85.76 |
5 | 2023 - Q4 (2023-12-31) | $23,505,242 | 14.64% | 254,827 | $64.79 |
6 | 2023 - Q3 (2023-09-30) | $19,037,900 | 17.25% | 379,090 | $53.44 |
7 | 2023 - Q2 (2023-06-30) | $28,375,978 | 15.72% | 448,987 | $54.36 |
8 | 2023 - Q1 (2023-03-31) | $28,021,077 | 11.61% | 622,829 | $45.05 |
9 | 2022 - Q4 (2022-12-31) | $25,487,256 | 9.57% | 581,768 | $47.96 |
10 | 2022 - Q3 (2022-09-30) | $34,544,000 | 12.45% | 524,268 | $64.23 |
11 | 2022 - Q2 (2022-06-30) | $36,192,000 | 12.35% | 716,539 | $58.58 |
12 | 2022 - Q1 (2022-03-31) | $49,925,000 | 7.33% | 781,539 | $71.78 |
13 | 2021 - Q4 (2021-12-31) | $69,144,000 | 7.84% | 645,539 | $104.60 |
14 | 2021 - Q3 (2021-09-30) | $53,633,000 | 9.74% | 521,673 | $93.12 |
15 | 2021 - Q2 (2021-06-30) | $39,451,000 | 10.25% | 448,512 | $91.63 |
16 | 2021 - Q1 (2021-03-31) | $41,129,000 | 7.43% | 423,012 | $99.84 |
17 | 2020 - Q4 (2020-12-31) | $42,618,000 | 8.85% | 380,012 | $105.38 |
18 | 2020 - Q3 (2020-09-30) | $35,757,000 | 3.78% | 385,727 | $77.01 |
19 | 2020 - Q2 (2020-06-30) | $24,572,000 | 4.95% | 315,029 | $67.64 |
20 | 2019 - Q2 (2019-06-30) | $0 | 0% | 0 | $82.54 |
21 | 2019 - Q1 (2019-03-31) | $2,451,000 | 1.08% | 30,618 | $73.89 |
The displayed share prices are average quarterly stock market prices.